Home > Boards > US Listed > Biotechs > Aravive - Oncology/Biotech Company (ARAV)

initial 10K shares purchased @ $7.20 yesterday upon

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
iDeVos Member Profile
 
Followed By 1
Posts 28
Boards Moderated 0
Alias Born 02/07/19
160x600 placeholder
Aravive to Participate in Fireside Chat at 2021 BTIG Biotechnology Conference GlobeNewswire Inc. - 7/27/2021 7:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 7/23/2021 4:07:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/15/2021 7:11:30 AM
Aravive Achieves Second Development Milestone from 3D Medicines GlobeNewswire Inc. - 7/15/2021 7:00:00 AM
Aravive to Participate in Fireside Chat at 2021 William Blair Biotech Focus Conference GlobeNewswire Inc. - 7/7/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 4:07:59 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 4:07:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2021 4:07:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 7:37:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 7:37:35 PM
Aravive shares surge on early-stage kidney cancer study data Seeking Alpha - 6/24/2021 7:45:17 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2021 7:07:54 AM
Aravive Announces Positive Initial Results from Phase 1b Portion of the Phase1b/2 Study of AVB-500 in Combination with Caboza... GlobeNewswire Inc. - 6/24/2021 7:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/21/2021 6:17:17 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/21/2021 5:22:22 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/21/2021 4:30:54 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/18/2021 7:06:19 AM
Aravive Announces Three New Appointments to its Board of Directors GlobeNewswire Inc. - 5/18/2021 7:00:00 AM
Aravive EPS beats by $0.01, misses on revenue Seeking Alpha - 5/6/2021 7:26:21 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2021 7:15:18 AM
Aravive Reports First Quarter 2021 Financial Results and Announces Plans to Investigate AVB-500 in Clinical Trial as First-L... GlobeNewswire Inc. - 5/6/2021 7:00:00 AM
Aravive shares rise after dosing first patient in late-stage ovarian cancer study Seeking Alpha - 4/27/2021 10:54:45 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/27/2021 7:11:36 AM
Aravive Announces First Patient Dosed in Phase 3 Registrational Trial Evaluating AVB-500 in Patients with Platinum Resistant... GlobeNewswire Inc. - 4/27/2021 7:00:00 AM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/15/2021 7:45:28 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences